APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,600,034 | +126.7% | 68,350 | +442.8% | 0.02% | +150.0% |
| Q2 2023 | $1,147,040 | +176367.7% | 12,591 | +27.7% | 0.01% | +60.0% |
| Q1 2023 | $650 | +27.7% | 9,860 | +0.1% | 0.01% | +25.0% |
| Q4 2022 | $509 | -99.9% | 9,848 | -0.2% | 0.00% | -33.3% |
| Q3 2022 | $657,000 | +56.1% | 9,863 | +6.1% | 0.01% | +50.0% |
| Q2 2022 | $421,000 | +343.2% | 9,300 | +400.0% | 0.00% | +300.0% |
| Q1 2022 | $95,000 | +14.5% | 1,860 | -9.3% | 0.00% | 0.0% |
| Q4 2021 | $83,000 | -49.1% | 2,050 | -58.6% | 0.00% | 0.0% |
| Q3 2021 | $163,000 | -12.4% | 4,952 | +67.9% | 0.00% | 0.0% |
| Q2 2021 | $186,000 | +46.5% | 2,950 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $127,000 | -24.9% | 2,950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $169,000 | +119.5% | 2,950 | +15.7% | 0.00% | 0.0% |
| Q3 2020 | $77,000 | +327.8% | 2,550 | +363.6% | 0.00% | – |
| Q2 2020 | $18,000 | +20.0% | 550 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |